1 URL (Links) /-/media/cslb-switzerland/documents/methodology_final_2019.pdf?la=en-us&hash=0F50D34C881A5D7510C248804F72E83ADED316BA
www.cslbehring.ch
Datum der Indexierung 04.05.2021 20:07:22
Textauszug aus Quelle
MetaInfo: Text: Methodology_Final May 2016 1 Last revised: May 2020 CSL Behring AG Guidelines for Abiding by the EFPIA Transparency Code as of the 2019 Reporting Year Preamble CSL Behring is a global leader in the plasma protein biotherapeutics industry. We research, develop, manufacture and market biotherapies that are used to treat serious and rare conditions. Users of our therapies rely on them for their quality of life and, in many cases, for life itself. Our commitment to saving lives and
mehr Text anzeigen: >>
Title (HTML) 0f50d34c881a5d7510c248804f72e83aded316ba:15 2019:9 ch:2 cslb:4 cslbehring:1 documents:6 en:12 final:8 hash:14 la:11 media:3 methodology:7 pdf:10 switzerland:5 us:13
HTML Description pdf?la=en-us&hash=0F50D34C881A5D7510C248804F72E83ADED316BA
Kombination Keywords healthcare efpia | approach from | question provide | professional case | that where | publish information | event contribution | professionals travel | with only | events background | granted publishing | details service | organisations data | consent third | development published | what consultancy | this relevant | costs research | publication transparency | last example | code organisation | continuous revised | which under | fees period | reporting such |
Anzahl Subdomain 2
Subdomain:
Log Metriken 19
outgoing (external) Links 0
Keywords in URL | cslb| documents| en| final| hash| la| media| methodology| pdf| switzerland| us
alle ausgehende (outbound) Domain in www.cslbehring.ch
alle eingehende (inbound) Domain in www.cslbehring.ch
Textauszug aus Quelle
MetaInfo: Text: Methodology_Final May 2016 1 Last revised: May 2020 CSL Behring AG Guidelines for Abiding by the EFPIA Transparency Code as of the 2019 Reporting Year Preamble CSL Behring is a global leader in the plasma protein biotherapeutics industry. We research, develop, manufacture and market biotherapies that are used to treat serious and rare conditions. Users of our therapies rely on them for their quality of life and, in many cases, for life itself. Our commitment to saving lives and
mehr Text anzeigen: >>
Title (HTML) 0f50d34c881a5d7510c248804f72e83aded316ba:15 2019:9 ch:2 cslb:4 cslbehring:1 documents:6 en:12 final:8 hash:14 la:11 media:3 methodology:7 pdf:10 switzerland:5 us:13
HTML Description pdf?la=en-us&hash=0F50D34C881A5D7510C248804F72E83ADED316BA
Kombination Keywords healthcare efpia | approach from | question provide | professional case | that where | publish information | event contribution | professionals travel | with only | events background | granted publishing | details service | organisations data | consent third | development published | what consultancy | this relevant | costs research | publication transparency | last example | code organisation | continuous revised | which under | fees period | reporting such |
Anzahl Subdomain 2
Subdomain:
Log Metriken 19
outgoing (external) Links 0
Keywords in URL | cslb| documents| en| final| hash| la| media| methodology| pdf| switzerland| us
alle ausgehende (outbound) Domain in www.cslbehring.ch
alle eingehende (inbound) Domain in www.cslbehring.ch